The deal values Icosavax at $15 per share in cash at closing, plus a non-tradable contingent value right for up to $5 per share in cash if certain milestones are met. The upfront payment of $15 apiece represents a premium of about 43% to U.S.-listed Icosavax's last close.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles